The capsules get pressed in a plant whose name is on none of the bottles.‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 
BOOMERS TRADE
Andrew James reporting. 64, and counting.
The only aisle that has to sell itself
Longevity is the stage the cohort walks into next. What the money does when it gets there is already visible in two federal surveys.
The cheap half never gets bought
Two routes lead to more good years. Only one of them comes with a barcode.
From our partners
Who has to build what. The air fleet route: the aircraft, landing pads built, a licensed operator, you buy a seat. The personal ownership route: the aircraft, your own garage, 25 hours of training, you fly it.
The route that does not wait for a city to pour concrete
There are two ways to put a person in the air on electric power. They ask for completely different things to happen first.
The air fleet route
Somebody builds landing pads across a city. An operator holds the certificate. A pilot on payroll flies it. You buy a seat once the network exists.
The ownership route
The aircraft fits in a two car garage and charges like an EV. It requires just 25 hours of training. You are the pilot, and nobody has to break ground.
Doroni Aerospace sells the second route. The H1-X is a two seat electric personal aircraft, built for a driveway rather than a terminal.
That route is shorter. It is still hard. Full scale test flights are targeted for 2027. Commercial deliveries are planned for 2028. Both dates rest on certification.
600+ reservations for the aircraft are already in, good for $240M+ in potential revenue from preorders. Doroni has raised over $35M to date. You can invest at $3.30 per share, with up to 20% bonus shares available for a limited time.
This is a paid advertisement for Doroni Regulation A offering. Please read the offering circular at https://invest.doroni.io
I take four of them. Fish oil, vitamin D, magnesium, and one my daughter put in the cart.
So this is not a lecture. It is arithmetic about a shelf I stand in front of too.
Two federal surveys count what this cohort actually does about getting older. Set them beside each other and the aisle explains itself.
75.9%
Adults 60 and over who took a dietary supplement in the past 30 days
15.5%
Adults 65 and over who met the federal activity guidelines in 2024
22%
Men 65 and over who met the strength half of those guidelines on its own
 
Three quarters of us buy something in a bottle. Fifteen in a hundred do the walking and the lifting both. Same cohort. Same goal.
Every dollar of the first figure comes out of your own pocket. No claim form, no card, no argument with anybody.
The second one costs a pair of shoes and two afternoons of your week.
That is the shape of the whole longevity aisle. The part that can be sold is the part that grows.
In every aisle behind this one, the calendar does the selling.
A bottle carries a barcode, a margin, a refill date, and a subscribe button. Each one of those is a reason for somebody to build a company around it.
Two sets of squats carry none of that. There is nothing there to build a company on.
The money sits one step behind the label. Most supplement brands do not own a factory.
They buy from a contract manufacturer. A plant that blends the powder, presses the capsules, and prints somebody else’s name on the bottle.
One plant runs forty brands. The brands fight each other for the shelf. The plant gets paid either way.
Where the cohort’s money sits this quarter, and the aisle it is walking into next.
 
Travel
The trip stage, mostly spent. The knees that made it possible are the reason the next aisle exists at all.
 
Health & Housing
The cohort is here this quarter
The bills that arrive whether or not anybody buys a thing. This aisle has never needed a marketing budget.
 
Longevity
Next in front of the money
It arrives with a shelf attached, which none of the earlier stages had. That is why it looks so much louder.
 
Estate
The handoff stage. Whatever the bottles did or did not do turns into a date on a form.
Who is already standing there
The private-label plant in an industrial park outside a mid-sized city. It blends, encapsulates, bottles and ships under forty labels, three of which advertise against each other. Brands arrive and fold on a two-year cycle, and the plant signs the next one, because the capsules still have to be pressed somewhere and the line is already running. Nobody has ever seen its name on a shelf.
That business has a ceiling, and it is a real one. The category rests on how people feel rather than on what a trial showed. One ingredient scare can empty a line for a year.
Regulation can move. A large retailer deciding to make its own squeezes the price overnight.
The other route has a catch too. Fifteen percent is a low number for a reason. Two sessions a week is easy to say and hard to keep through a bad knee and a long February.
The arithmetic
Share of adults age 60 and over who used any dietary supplement in the past 30 days, 75.9 percent: National Center for Health Statistics, Data Brief 561, May 2026, from NHANES August 2021 to August 2023. Share of adults 65 and over meeting the federal guidelines for both aerobic and muscle-strengthening activity, 15.5 percent in 2024: National Health Interview Survey, reported through Healthy People 2030; the same measure read 13.9 percent in 2022 in National Health Statistics Reports 215. Share of men 65 and over meeting the muscle-strengthening guideline alone, 22 percent: National Health Interview Survey 2020. The four bottles on my counter are mine, and the monthly cost is my own arithmetic rather than a national figure.
 
I will keep taking the four. They run me about forty dollars a month, and I have made my peace with that. The other route is already on the calendar for Tuesday and Friday. Only one of those two has a company behind it that needs me to keep going. Watch which one gets advertised to you this winter.
Andrew
Boomers Trade is written by someone getting older right alongside you, and watching who profits from it.